2802
Helvetica Chimica Acta Vol. 87 (2004)
63.9 (2d, CH2); 87.3 (s, Ar3CO); 113.4, 122.9, 123.1, 123.4, 126.7, 127.0, 127.2, 128.0, 128.2, 128.3, 128.5, 130.2,
130.41 (13d, arom. C); 130.45, 131.1, 131.4, 132.6, 135.7, 139.5, 144.6, 158.7 (8s, arom. C). ESI-MS (pos.):
563.2213 (C37H32O4Na ; calc. 563.2198).
Chloroacetic Acid [2-(Hydroxymethyl)phenanthren-1-yl]methyl Ester (7).
A soln. of 5 (100 mg,
0.186 mmol), collidine (40 mg, 0.33 mmol), and chloroacetic anhydride (38 mg, 0.22 mmol) in CH2Cl2
(0.4ml) was stirred for 15 min at r.t. The reaction was quenched by the addition of 10% citric acid soln. in
H2O (50 ml), the mixture extracted with CH2Cl2 (3 Â 50 ml), and the org. phase dried (MgSO4) and
evaporated. The crude was dissolved in HCOOH/THF/EtOH 50 :35 :15 (v/v; 6 ml), and the soln. was stirred for
20 min at r.t. After addition of 1m NH4Cl in H2O (10 ml), THF and EtOH were evaporated. The residue was
extracted with CH2Cl2 (3Â), the org. phase dried (MgSO4) and evaporated, and the crude adsorbed on SiO2
(300 mg). Purification by FC (SiO2 (2 g); hexane ! hexane/AcOEt 8 :2) gave 7 (18 mg, 32%). White solid. TLC
(hexane/AcOEt 7:3): Rf 0.15. 1H-NMR (400 MHz, CDCl3): 4.06 (s, CH2Cl); 5.05 (d, J 5.6, CH2OH); 5.92 (s,
ArCH2O); 7.62 7.71 (m, HÀC(6), HÀC(7)); 7.74( d, J 8.6, HÀC(3)); 7.86, 8.04(2 d, J 9.3, HÀC(9),
HÀC(10)); 7.92 (dd, J 1.1, 7.4, HÀC(8)); 8.70 (d, J 8.2, HÀC(5)); 8.77 (d, J 6.6, HÀC(4)). NOE (irr.
Signal ! affected signals): 5.05 (CH2OH) ! 2.32 (d, OH; 1.6%), 5.92 (d, ArCH2OC; 3.0%), and 7.74( d,
HÀC(3); 3.7%); 5.92 (ArCH2OC) ! 5.05 (d, CH2OH; 4.5%) and 8.04 (d, HÀC(10); 8.4%); 8.04 (HÀC(10)) !
5.92 (d, ArCH2OC; 8.7%), 7.86 (d, HÀC(9); 2.4%), and 7.92 (neg. d, artefact), but no effect at 8.77 (d, J 6.6,
HÀC(4)). 13C-NMR (75 MHz, (D6)MSO): 46.4, 65.8, 66.1 (3d, CH2); 127.7, 128.2, 129.3, 131.8, 132.1, 132.3,
132.9 (7d, arom. C); 133.4( s, arom. C); 133.5 (d, arom. C); 134.4, 135.0, 136.0, 136.1, 146.1 (5s, arom. C); 172.6 (s,
CO). ESI-MS (pos.): 314.0710 (C18H15ClO3 ; calc. 314.0710).
{2-{[(4,4'-Dimethoxytrityl)oxy]methyl}phenanthren-1-yl}methyl Diisopropylphosphoramidite (1). A soln.
of 5 (340 mg, 0.6 mmol) and iPr2NEt (270 ml, 1.6 mmol) in CH2Cl2 (4ml) was treated with 2-cyanoethyl
diisopropylphosphoramidochloridite (200 mg, 0.8 mmol), stirred for 2 h at r.t., and then purified by FC SiO2
(6 g), hexane (2% Et3N) ! hexane/AcOEt 7:3 (2% Et3N): 1 (390 mg, 88%). White foam. TLC (hexane/
1
AcOEt 7:3): Rf 0.65. H-NMR (300 MHz, CDCl3): 0.92, 1.05 (2d, J 6.8, (Me2CH)2N); 2.35 (dt, J 3.2, 1.1,
OCH2CH2CN); 3.47 3.59 (m, (Me2CH)2N, OCH2CH2CN); 3.73 (s, MeO); 4.51 (s, ArCH2OC); 4.97 5.15 (m,
ArCH2OP); 6.84 6.89 ( m, 4arom. H); 7.21 7.36 ( m, 3 arom. H); 7.42 7.47 (m, 4arom. H); 7.53 7.69 ( m, 4
arom. H); 7.80 (d, J 9.2, HÀC(9)); 7.90 (d, J 8.5, HÀC(8)); 8.15 (d, J 9.2, HÀC(10)); 8.72, 8.75 (2d, J
9.0, 8.8, HÀC(4), HÀC(5)). 13C-NMR (75 MHz, CDCl3): 20.1 (t, J(C,P) 6.8, CH2CN); 24.50, 24.60, (2q,
J(C,P) 7, ( Me2CH)2N); 43.2 (d, J(C,P) 12, (Me2CH)2N); 55.2 (q, MeO); 58.4, 58.8 (2d, J(C,P) 20, 17,
ArCH2OP, POCH2CH2CN); 64.0 (d, ArCH2OC); 86.8 (s, Ar3CO); 113.2 (d, arom. C); 117.6 (s, CN); 122.7, 123.1,
123.31, 123.34, 126.5, 126.6, 126.7, 126.8, 127.2, 127.9, 128.3, 128.4, 130.2 (13d, arom. C); 130.4, 131.1, 131.5, 132.5,
132.6, 136.2, 136.3, 145.1, 158.5 (9s, arom. C). 31P-NMR (121 MHz, CDCl3): 149.2. ESI-MS (pos.): 763.3259
(C46H49N2O5PNa ; calc. 763.3276).
Solid support 8 ({4-{2-[(Controlled-pore-glass)amino]-2-oxoethoxy}phenoxy}acetic Acid {2-{[(4,4'-Di-
methoxytrityl)oxy]methyl}penanthren-1-yl}methyl Ester). A soln. of 5 (116 mg, 0.21 mmol), [1,4-phenylenebi-
s(oxy)]bis[acetic acid] (97 mg, 0.43 mmol), DMAP (5 mg, 0.04 mmol), and iPr2NEt (185 ml, 1.1 mmol) in
pyridine (2 ml) was treated with BOP (190 mg, 0.43 mmol) and kept for 30 min at r.t. The mixture was diluted
with CH2Cl2 (20 ml) and 10% citric acid soln. in H2O (30 ml). After extraction with CH2Cl2 (3 Â 20 ml), the
org. phase was washed with sat. aq. NaHCO3 soln., dried (MgSO4) and evaporated and the crude purified by FC
(SiO2 (1 g), CH2Cl2 (2% Et3N) ! CH2Cl2/MeOH 19 :1 (2% Et3N)) to give the intermediate as Et3NH salt.
1H-NMR (300 MHz, CDCl3): 1.25 (t, J 7.4, ( Me2CH2)3N); 2.99 (q, J 7.4, (Me2CH2)3N); 3.69 (s, MeO); 4.32,
4.34, 4.35, 5.54 (4s, CH2); 6.62 6.79 (m, 8 arom. H); 7.13 7.78 (m, 15 arom. H); 8.61 8.69 (m, HÀC(4),
HÀC(5)).
The intermediate (25 mg, 0.03 mmol) was dissolved in a suspension of (long-chain-alkyl)amino controlled-
i
pore glass (LCAA-CGP; 500 mg), Pr2NEt (60 ml, 0.36 mmol), and BOP (13 mg, 0.03 mmol) in MeCN and
shaken for 20 h at r.t. After filtration, the solid phase was washed with MeCN and CH2Cl2, suspended in pyridine
(1.5 ml) and Ac2O (0.5 ml), and shaken for 2 h at r.t. The solid was filtered and washed with DMF and CH2Cl2.
Loading density (trityl monitoring): 26 mmol/g.
3. Synthesis and Purification of Oligonucleotides. Oligonucleotides were synthesized on a 392-DNA/RNA
synthesizer (Applied Biosystems) according to the phosphoramidite chemistry [24][25]. The deoxynucleoside
phosphoramidites were from ChemGenes (Ashland, MA). Oligonucleotides were prepared by the standard
synthetic procedure (−trityl-off× mode), by using 1.1m tert-butyl hydroperoxide (in hexane/1,2-dichlorethane 1:4)
as the oxidant. For the phenanthrenylmethyl phosphoramidite 1, used as a 0.1m soln. in 1,2-dichloroethane, the
coupling time was increased to 50 s in the presence of 0.25m 5-(benzylthio)-1H-tetrazole in MeCN as activator.
Cleavage from the solid support and final deprotection was achieved by treatment with 30% NH4OH soln.